Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yasushi, Fuchigami"'
Autor:
Masashi Takeda, Soki Kashima, Yasushi Fuchigami, Takayuki Yoshino, Tatsuki R. Kataoka, Toshinari Yamasaki, Hiroshi Kagamu, Takashi Kobayashi, Shusuke Akamatsu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Renal cell carcinoma unclassified with medullary phenotype (RCCU-MP) is an extremely rare variant of kidney cancer with poor prognosis. Recently, immune checkpoint inhibitors (ICIs) have been the mainstay of treatment for advanced clear cell renal ce
Externí odkaz:
https://doaj.org/article/06d5c2f350a84d53b92fbb5e955f14da
Autor:
Masafumi, Tsuruta, Noboru, Shibasaki, Ryo, Iguch, Takahiro, Yamaguchi, Hideto, Ota, Yasushi, Fuchigami, Toshihiro, Magaribuchi, Hirohito, Naito, Akito, Terai
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 66(12)
A 47-year-old man was referred to our hospital for epigastric pain and cough, and was given a diagnosis of left clear cell renal carcnoma with multiple pulmonary metastases based on the results of renal tumor biopsy (cT3aN0M1). He received nivolumab/
Autor:
Takuya, Hida, Toshinari, Yamasaki, Haruka, Banno, Yasushi, Fuchigami, Kodai, Hattahara, Maki, Fujiwara, Ryosuke, Suzuki, Yuki, Kita, Takayuki, Yoshino, Takayuki, Goto, Atsuro, Sawada, Shusuke, Akamatsu, Ryoichi, Saito, Takashi, Kobayashi, Takahiro, Inoue, Osamu, Ogawa
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 65(10)
Peritoneal dissemination or metastasis is a relatively rare presentation of renal cell carcinoma. We report four cases of advanced renal cell carcinoma with peritoneal metastases treated with nivolumab. Three cases showed an objective response in the
Autor:
Kodai, Hattahara, Toshinari, Yamasaki, Atsuro, Sawada, Katsuya, Tanigaki, Syuichiro, Endo, Yuki, Teramoto, Haruka, Banno, Yasushi, Fuchigami, Ryosuke, Suzuki, Maki, Fujiwara, Takuya, Hida, Takayuki, Yoshino, Yuki, Kita, Takayuki, Goto, Shusuke, Akamatsu, Ryoichi, Saito, Takashi, Kobayashi, Takahiro, Inoue, Osamu, Ogawa
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 65(5)
A 43-year-old man underwent nephrectomy for right renal cell carcinoma (cT3aN0M1 (PUL), clear cell carcinoma). Thereafter, he was treated with sunitinib for lung metastases as the first-line therapy for three months. Because lung metastases progresse